This Chart Is Why I'm Not Worried About Guardant Health
- Oops!Something went wrong.Please try again later.
- GH
Guardant Health (NASDAQ: GH) creates blood tests that inform oncologists of possible treatment options for cancer. It also offers a battery of testing that can alert clinicians to disease recurrence. This is commonly referred to as a liquid biopsy, a blood draw that could potentially replace invasive surgical biopsies.